Anaphylaxis Associated With Allergen Specific Immunotherapy, Omalizumab, and Dupilumab: A Real World Study Based on the US Food and Drug Administration Adverse Event Reporting System

Overview of attention for article published in Frontiers in Pharmacology, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

So far, Dimensions has found 12 publications that cite this research output.

Article in Expert Opinion on Drug Safety (September 2024)

Article in Minerva Respiratory Medicine (March 2024)

Article in Frontiers in Pharmacology (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.